Image

Global Preimplantation Genetic Screening (PGS) Technology Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Preimplantation Genetic Screening (PGS) Technology Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Preimplantation Genetic Screening (PGS) Technology Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 552.50 Million
Diagram Market Size (Forecast Year) USD 1,228.09 Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Product and Services (Reagents and Consumables, Instruments, Software and Services), End User (Maternity Centers and Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories and Academic Institutes), Test Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, HLA Typing, Other PGT Types), Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Disease, Others) – Industry Trends and Forecast to 2029

Preimplantation Genetic Screening (PGS) Technology Market

Preimplantation Genetic Screening (PGS) Technology Market Analysis and Size

The size of the global market for preimplantation genetic screening (PGS) technology is anticipated to grow at a CAGR of 10.50% during the forecast period. Recent technological developments have significantly altered the practice of prenatal screening and early diagnosis of chromosomal abnormalities in an embryo. Successful in vitro fertilisation (IVF) processing has been achieved by expanding non-invasive cell-free foetal DNA-based detection procedures as well as carrier screening panels into prenatal care. Preimplantation genetic screening (PGS) technology is a market-driver due to the early detection of congenital disorders in the beginning phases of the IVF workflow, gradually reducing the chance of inherited chromosomal abnormalities in foetuses.

Data Bridge Market Research analyses that the preimplantation genetic screening (PGS) technology market which was USD 552.50 million in 2021, would rocket up to USD 1228.09 million by 2029, and is expected to undergo a CAGR of 10.50% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Preimplantation Genetic Screening (PGS) Technology Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Procedure Type (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism), Product and Services (Reagents and Consumables, Instruments, Software and Services), End User (Maternity Centers and Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories and Academic Institutes), Test Type (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, HLA Typing, Other PGT Types), Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Disease, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Abbott (U.S.), Siemens (Germany), QIAGEN (Germany)

Market Opportunities

  • Rising number of fertility clinics around the world
  • Prevalence of funds from government and private organisations for preimplantation genetic screening

Market Definition

Preimplantation genetic screening (PGS), also known as PGTa (preimplantation testing for aneuploidy), is a specialised, cutting-edge diagnostic procedure used to ascertain the chromosomal status of embryos at a very early stage of embryo development. It is an additional or "add-on" to standard IVF/ICSI therapy.

Preimplantation Genetic Screening (PGS) Technology Market Dynamics

Drivers

  • Rising number of fertility clinics

In the forecast period of 2022–2029, factors such as the rising number of fertility clinics around the world, the prevalence of funds from government and private organisations for preimplantation genetic screening, the declining rate of fertility, the adoption of cutting-edge technology, and the rising risk of chromosomal abnormalities with increasing maternal age are likely to boost the growth of the preimplantation genetic screening (PGS) technology market.

  • Increase in healthcare infrastructure

The preimplantation genetic screening (PGS) technology market will expand throughout the forecast period due to the prevalence of an enhanced healthcare infrastructure and an increase in tourist activities.

Opportunities

The growth of the preimplantation genetic screening (PGS) technology market is fuelled by the prevalence of funds from government and private organisations for preimplantation genetic screening, the declining fertility rate, and the adoption of cutting-edge technology. This will provide beneficial opportunities for the market growth.

Restraints/Challenges

  • High cost

On the other hand, the stringent government regulations and the high procedure cost will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the preimplantation genetic screening (PGS) technology market.

This preimplantation genetic screening (PGS) technology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the preimplantation genetic screening (PGS) technology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Preimplantation Genetic Screening (PGS) Technology Market Scope

The preimplantation genetic screening (PGS) technology market is segmented on the basis of procedure type, technology, product & services, test type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Procedure Type

  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis

 Technology

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Fluorescence in Situ Hybridization
  • Comparative Genomic Hybridization
  • Single-Nucleotide Polymorphism

 Product and Services

  • Reagents and Consumables
  • Instruments
  • Software and Services

End User

  • Maternity Centers
  • Fertility Clinics
  • Hospitals, Diagnostic Labs
  • Service Providers
  • Research Laboratories
  • Academic Institutes

 Test Type

  • Chromosomal Abnormalities
  • X-linked Diseases, Embryo Testing
  • Aneuploidy Screening
  • HLA Typing
  • Other PGT Types

 Application

  • Embryo HLA Typing for Stem Cell Therapy
  • IVF Prognosis
  • Late Onset Genetic Disorders
  • Inherited Genetic Disease
  • Others

Preimplantation Genetic Screening (PGS) Technology Market Regional Analysis/Insights

The preimplantation genetic screening (PGS) technology market is analysed and market size insights and trends are provided by country, procedure type, technology, product & services, test type, application and end user as referenced above.

The countries covered in the preimplantation genetic screening (PGS) technology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the preimplantation genetic screening (PGS) technology market due to the growing number of late pregnancies along with rising adoption of IVF procedures.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing number of advancements and adoption of PGT workflows.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Preimplantation Genetic Screening (PGS) Technology Market Share Analysis

The preimplantation genetic screening (PGS) technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to preimplantation genetic screening (PGS) technology market.

Some of the major players operating in the preimplantation genetic screening (PGS) technology market are:

  • Illumina, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • PerkinElmer, Inc. (U.S.)
  • CooperSurgical, Inc. (U.S.)
  • Beijing Genomics Institute (BGI) (China)
  • Abbott (U.S.)
  • Siemens (Germany)
  • QIAGEN (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The preimplantation genetic screening (PGS) technology market value is projected at USD 1228.09 million by 2029.
The Preimplantation Genetic Screening (PGS) Technology Market is to grow at a CAGR of 10.50% during the forecast by 2029.
On the basis of technology, the Preimplantation Genetic Screening (PGS) Technology Market is segmented into Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-Nucleotide Polymorphism.
On the basis of application, the Preimplantation Genetic Screening (PGS) Technology Market is segmented into Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Disease, Others.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials